These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12902114)

  • 1. Primary lymphoepithelioma of the esophagus.
    Angulo-Pernett F; Smythe WR
    Ann Thorac Surg; 2003 Aug; 76(2):603-5. PubMed ID: 12902114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
    Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR
    Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic effects of neoadjuvant therapies for advanced squamous cell carcinoma of the esophagus: multivariate analysis of predictive factors and p53 overexpression.
    Kajiyama Y; Hattori K; Tomita N; Amano T; Iwanuma Y; Narumi K; Udagawa H; Tsurumaru M
    Dis Esophagus; 2002; 15(1):61-6. PubMed ID: 12060045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma.
    Yamamoto S; Ishihara R; Motoori M; Kawaguchi Y; Uedo N; Takeuchi Y; Higashino K; Yano M; Nakamura S; Iishi H
    Am J Gastroenterol; 2011 Jun; 106(6):1048-54. PubMed ID: 21343920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review.
    Kam TY; Kountouri M; Roth A; Frossard JL; Huber O; Mönig S; Zilli T
    Crit Rev Oncol Hematol; 2018 Apr; 124():61-65. PubMed ID: 29548487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemoradiotherapy in patients with surgically treated T4 esophageal squamous cell carcinnoma].
    Shiozaki H; Yano M
    Nihon Geka Gakkai Zasshi; 2002 Mar; 103(3):284-9. PubMed ID: 11968758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system.
    Gertler R; Stein HJ; Langer R; Nettelmann M; Schuster T; Hoefler H; Siewert JR; Feith M
    Ann Surg; 2011 Apr; 253(4):689-98. PubMed ID: 21475008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management for patients with advanced T4 epidermoid carcinoma of the esophagus.
    Wang LS; Chi KH; Hu MH; Fahn HJ; Huang MH
    J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
    Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen.
    Yang Q; Cleary KR; Yao JC; Swisher SG; Roth JA; Lynch PM; Komaki R; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Dis Esophagus; 2004; 17(1):38-43. PubMed ID: 15209739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma of the esophagus: treat with how many modalities?
    Cheng S; Iannettoni M; Koshy M; Suntharalingam M; Urba S
    Semin Oncol; 2009 Dec; 36(6):493-7. PubMed ID: 19995639
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic strategies for advanced respectable esophageal cancer].
    Kitagawa Y
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):333-7. PubMed ID: 19068714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
    Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimodal therapy in squamous cell carcinoma of the esophagus.
    Matuschek C; Bölke E; Zahra T; Knoefel WT; Peiper M; Budach W; Erhardt A; Scherer A; Baldus SE; Gerber PA; Buhren BA; Schauer M; Hoff NP; Gattermann N; Orth K
    Eur J Med Res; 2011 Oct; 16(10):437-44. PubMed ID: 22024422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer.
    Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Morii E; Mori M; Doki Y
    Ann Surg; 2011 Feb; 253(2):279-84. PubMed ID: 21169807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.
    Raouf AA; Evoy DA; Carton E; Mulligan E; Griffin MM; Reynolds JV
    Dis Esophagus; 2003; 16(1):17-23. PubMed ID: 12581249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi-modality (chemo-radiation) versus tri-modality (chemo-radiation followed by surgery) treatment for carcinoma of the esophagus.
    Chan R; Morrill S; Freeman D; Colman M; Zwischenberger J
    Dis Esophagus; 2001; 14(3-4):202-7. PubMed ID: 11869320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.